RBC Capital upgraded Fisher & Paykel Healthcare to Sector Perform from Underperform with a price target of NZ$36, up from NZ$31. The firm cites the company’s better guidance for the upgrade.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on FSPKF:
- Fisher & Paykel Healthcare Lifts FY26 Guidance as Hospital Demand and Margins Improve
- Fisher & Paykel Healthcare Discloses Shareholding of New Director Anna Curzon
- Pinnacle Investment Management Takes 5% Stake in Fisher & Paykel Healthcare
- Fisher & Paykel Healthcare strengthens board with tech and health-sector appointments
- Fisher & Paykel Healthcare Corrects Director Shareholding Disclosure